Xcout IntelSign inSubscribe

ROSE DIAGNOSTICS INC. competitors & alternatives

United States

The 12 closest competitors and alternatives to ROSE DIAGNOSTICS INC. — ranked by similarity to what ROSE DIAGNOSTICS INC. actually does, not by market-cap band.

12Competitors listed

Subscribe to see ROSE DIAGNOSTICS INC.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About ROSE DIAGNOSTICS INC.

ROSE Diagnostics Inc. is a healthcare and biotechnology company headquartered in Carlsbad, California. The company bridges the gap between pathology labs and cancer biopsies, notably developing the verifi LUNG test.

ROSE DIAGNOSTICS INC. at a glance

ROSE DIAGNOSTICS INC. is a company headquartered in United States. Its most recent funding round raised $2.2M in July 2026. Xcout tracks 10 named people at ROSE DIAGNOSTICS INC., including Andrew Morris (President).

ROSE DIAGNOSTICS INC. leadership

  • Andrew MorrisPresident
  • Andrew MorrisCEO, Founder
  • Adolfo VelazquezCTO, Founder
  • Donna PadavanVP Clinical & Regulatory Affairs, Founder
  • Eric BrouwerCSO, Founder
  • Adolfo VelazquezExecutive Officer

4 more named people on record for ROSE DIAGNOSTICS INC., with roles, board committees and tenure — see the full roster →

ROSE DIAGNOSTICS INC. funding rounds

Every round on record:

DateRoundAmountInvestors
SEC Form D filing$2.2M—
SEC Form D filing$2.3M—
SEC Form D filing$1M—
Seed$1M—

Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →

Top 12 ROSE DIAGNOSTICS INC. competitors

Ranked by semantic similarity — how close each company is to ROSE DIAGNOSTICS INC. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

Castle Biosciences, Inc.CSTL · Medical - Diagnostics & ResearchFriendswood, United States
68% matchPublic

Medical - Diagnostics & Research

Castle Biosciences, Inc. functions as a commercial-stage diagnostics firm, with its primary objective being the provision of both diagnostic and prognostic testing services, specifically targeting various dermatological cancers. Their flagship product, DecisionDx-Melanoma, represents an advanced multi-gene expression profile (GEP) assay engineered to assess the probability of metastasis in patients afflicted with invasive cutaneous melanoma. In addition to their leading solution, the company has created several other specialized, proprietary tests. Among these is DecisionDx-UM, a GEP test tailored to forecast the risk of metastasis for individuals with uveal melanoma, a less common malignancy of the eye. Another key offering is DecisionDx-SCC, a distinctive 40-gene expression profile test that utilizes a patient's unique tumor biology to predict their specific risk of squamous cell carcinoma metastasis, particularly for those presenting with recognized risk factors. Moreover, they offer DecisionDx DiffDx-Melanoma and myPath Melanoma, both proprietary GEP tests employed to assist in the accurate diagnosis of ambiguous pigmented lesions. These specialized testing services are provided by Castle Biosciences to patients predominantly through their healthcare providers. The organization commenced operations in 2007 and maintains its corporate headquarters in Friendswood, Texas.

Market cap$1B
Employees883
Castle Biosciences, Inc. competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of ROSE DIAGNOSTICS INC. and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for ROSE DIAGNOSTICS INC.and every competitor above — in one live dashboard.

Subscribe to Xcout Intel →